{"transactions":[{"id":962100,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-12-19T11:41:09.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/19/2025 and will vest in equal installments monthly, in arrears, over 36 months (1/36 per month)"}],"balance_after":25445,"derivative":{"exercise_price":1.29,"expiration_date":"2030-12-18","underlying":"Common shares","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001213900-25-123633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390025123633/ownership.xml","form_type":"4"}},{"id":965168,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Expiration)","published_at":"2025-12-17T12:17:57.000Z","date":"2025-12-15","kind":"other","planned":false,"acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$1,925.00 using an exchange rate of C$1.3770 = $US1.00"}],"balance_after":7445,"derivative":{"exercise_price":1397.97,"exercise_date":"2020-12-16","expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":60},"source":{"system":"sec-edgar","filing":"0001213900-25-122645","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390025122645/ownership.xml","form_type":"4"}},{"id":1322919,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-12-23T09:24:14.000Z","date":"2024-12-20","kind":"grant","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/20/2024 and will vest in equal installments monthly over 36 months (1/36 per month)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 14, 2024, the common stock of InMed was reverse split on a 1-for-20 basis. This number reflects that reverse stock split."}],"balance_after":7505,"derivative":{"exercise_price":4.14,"expiration_date":"2029-12-19","underlying":"Common shares","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001213900-24-111563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390024111563/ownership.xml","form_type":"4"}},{"id":1500565,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Expiration)","published_at":"2024-05-28T16:27:14.000Z","date":"2024-05-27","kind":"other","planned":false,"acquired":false,"shares":394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00"}],"balance_after":75100,"derivative":{"exercise_price":263.18,"exercise_date":"2019-05-27","expiration_date":"2024-05-27","underlying":"Common shares","underlying_shares":394},"source":{"system":"sec-edgar","filing":"0001213900-24-047096","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390024047096/ownership.xml","form_type":"4"}},{"id":1700184,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-12-26T13:09:00.000Z","date":"2023-12-23","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month)."}],"balance_after":75494,"derivative":{"exercise_price":0.37,"expiration_date":"2028-12-22","underlying":"Common shares","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001213900-23-098494","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390023098494/ownership.xml","form_type":"4"}},{"id":1720171,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Expiration)","published_at":"2023-12-06T09:02:25.000Z","date":"2023-12-05","kind":"other","planned":false,"acquired":false,"shares":848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Converted from the Canadian dollar exercise price of C$367.125 using an exchange rate of C$1.3579 = $US1.00"}],"balance_after":10494,"derivative":{"exercise_price":270.36,"exercise_date":"2018-12-05","expiration_date":"2023-12-05","underlying":"Common shares","underlying_shares":848},"source":{"system":"sec-edgar","filing":"0001213900-23-093299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390023093299/ownership.xml","form_type":"4"}},{"id":2081833,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-12-19T16:58:56.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 12/16/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":11342,"derivative":{"exercise_price":1.78,"expiration_date":"2027-12-15","underlying":"Common shares","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-22-080983","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390022080983/ownership.xml","form_type":"4"}},{"id":2110496,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-18T19:33:45.000Z","date":"2022-11-14","kind":"disposition_to_issuer","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 7,500 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,842 derivative securities of the Issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 7,500 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,842 derivative securities of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the Issuer's common stock was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On November 14, 2022, the reporting person reported the grant of an employee stock option to buy 7,500 shares of the Issuer's common stock at an exercise price of $2.78 per share. Such employee stock option was issued in error and has been cancelled. As of November 18, 2022, the reporting person beneficially owns 3,842 derivative securities of the Issuer."}],"balance_after":3842,"derivative":{"exercise_price":2.78,"expiration_date":"2027-11-13","underlying":"Common shares","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-22-073942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390022073942/ownership.xml","form_type":"4/A","original_submission_date":"2022-11-15"}},{"id":2116396,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-11-15T19:51:05.000Z","date":"2022-11-14","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 11/14/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On September 7, 2022, the common stock of InMed was reverse split on a 1-for-25 basis. This number reflects that reverse stock split."}],"balance_after":11342,"derivative":{"exercise_price":2.78,"expiration_date":"2027-11-13","underlying":"Common shares","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001213900-22-072923","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390022072923/ownership.xml","form_type":"4"}},{"id":2369213,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-28T14:20:02.000Z","date":"2022-02-23","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 2/23/2022 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."}],"balance_after":96060,"derivative":{"exercise_price":1.01,"expiration_date":"2027-02-22","underlying":"Common shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001213900-22-009673","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390022009673/ownership.xml","form_type":"4"}},{"id":2539478,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chem/Manufacturing/Control"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-10-19T18:23:48.000Z","date":"2021-10-18","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 10/18/2021 and will vest as follows: 25% of stock options will vest 6 months after the date of Grant; 25% of stock options will vest 12 months after the date of the Grant; 25% stock options will vest 18 months after the date of the Grant; and 25% stock options will vest 24 months after the date of the Grant."}],"balance_after":91060,"derivative":{"exercise_price":1.4,"expiration_date":"2026-10-17","underlying":"Common shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-21-053587","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390021053587/ownership.xml","form_type":"4"}},{"id":2938165,"issuer":{"id":8139,"kind":"organization","name":"InMed Pharmaceuticals Inc.","symbol":"INM"},"owners":[{"id":71097,"kind":"person","name":"WOUDENBERG MICHAEL","position":1,"cik":"0001817884","reported_name":"WOUDENBERG MICHAEL","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Chem/Manufacturing/Control"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-18T11:59:31.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Canadian exercise price of C$3.85 was converted into U.S. dollars using an exchange rate of C$1.2753 = US$1.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options were granted on 12/16/2020 and will vest as follows: 25% on 6/16/2021; 25% on 12/16/2021; 25% on 6/16/2022; and 25% on 12/16/2022."}],"balance_after":30000,"derivative":{"exercise_price":3.02,"expiration_date":"2025-12-15","underlying":"Common shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001213900-20-043408","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817884/000121390020043408/ownership.xml","form_type":"4"}}]}